APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE ε4 on Alzheimer’s Disease Risk in a Multiracial Sample
Choi, Kyu⋅Lee, Jang⋅Gunasekaran, Tamil⋅Kang, Sarang⋅Lee, Wooje⋅Jeong, Jangho⋅Lim, Ho⋅Zhang, Xiaoling⋅Zhu, Congcong⋅Won, So-Yoon⋅Choi, Yu⋅Seo, Eun⋅Lee, Seok⋅Gim, Jungsoo⋅Chung, Ji⋅Chong, Ari⋅Byun, Min⋅Seo, Sujin⋅Ko, Pan-Woo⋅Han, Ji-Won⋅McLean, Catriona⋅Farrell, John⋅Lunetta, Kathryn⋅Miyashita, Akinori⋅Hara, Norikazu⋅Won, Sungho⋅Choi, Seong-Min⋅Ha, Jung-Min⋅Jeong, Jee⋅Kuwano, Ryozo⋅Song, Min⋅An, Seong⋅Lee, Young⋅Park, Kyung⋅Lee, Ho-Won⋅Choi, Seong⋅Rhee, Sangmyung⋅Song, Woo⋅Lee, Jung⋅Mayeux, Richard⋅Haines, Jonathan⋅Pericak-Vance, Margaret⋅Choo, IL⋅Nho, Kwangsik⋅Kim, Ki-Woong⋅Lee, Dong⋅Kim, SangYun⋅Kim, Byeong⋅Kim, Hoowon⋅Jun, Gyungah⋅Schellenberg, Gerard⋅Ikeuchi, Takeshi⋅Farrer, Lindsay and Lee, Kun
Journal of Clinical Medicine, vol. 8, (no. 8), pp. 1236, 2019-08-16. | Journal Article